Biopharma predictions for 2026: thoughts from LEK Consulting’s Simon Middleton
An Expert View piece looking forward to next year from the global strategy consultancy's Simon Middleton, head, Europe Life Sciences and partner.
Regulation will play an increasingly central role
Regulation will play a bigger role in shaping development decisions, especially in Europe, where efforts to update rules on evidence requirements, unmet needs, and incentives are ongoing. Examples include ongoing reforms to European Union (EU) pharmaceutical legislation, including the Critical Medicines Act and EU Pharma Package and Medicines and Healthcare products Regulatory Agency (MHRA) plans to install sovereign marketing authorization and point-of-care manufacturing frameworks in the UK.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze